GLP-1 Weight-Loss Drugs Quietly Trim Cravings for Alcohol
TL;DR
Weight‑loss meds like Wegovy, Ozempic, and Mounjaro (GLP-1 agonists) may also dampen alcohol cravings and consumption for some users. Reports and early studies show people drinking less—some with strong nausea or fullness after alcohol—while others notice little change. While these effects could aid weight loss and alter drinking habits, safety concerns, potential off-label use for alcohol use disorder, and the need for larger, longer studies mean regulators haven’t endorsed using these drugs for addiction treatment beyond obesity/diabetes populations.
- How weight-loss medication is changing relationships with alcohol BBC
- Durham VA joins national trial testing GLP-1 medications for alcohol use disorder ABC11 News
- Semaglutide: A New Treatment Option for AUD? Medscape
- Ozempic Could Fight Addiction Too – Scientists Finally Know How SciTechDaily
- A New Use for a Familiar Medication? | North Shore Journal | Two Harbors, Silver Bay & Lake Superior northshorejournal.co
Want the full story? Read the original reporting
Read on BBC